PMH7- CHANGES IN SCHIZOPHRENIA-RELATED TOTAL DIRECT MEDICAL COSTS FOLLOWING INITIATION OF OLANZAPINE OR RISPERIDONE IN A PRIVATELY INSURED POPULATION IN THE UNITED STATES
Sep 1, 2001, 00:00 AM
10.1016/S1098-3015(11)71616-3
https://www.valueinhealthjournal.com/article/S1098-3015(11)71616-3/fulltext
Section Title :
Section Order :
130
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71616-3&doi=10.1016/S1098-3015(11)71616-3